Growth Hormone Stimulation Test: How Nutrition and Fasting Affect Your Results

At a glance
- Standard fast required / 8 to 12 hours before most GH stimulation tests
- Adult GH deficiency cut-off (insulin tolerance test) / peak GH <3 ng/mL (some labs use <5 ng/mL)
- Adult GH deficiency cut-off (GHRH-arginine) / peak GH <9 ng/mL (BMI-adjusted)
- Macimorelin cut-off (FDA-approved, 2017) / peak GH <2.8 ng/mL
- Elevated free fatty acids from a high-fat meal / can blunt peak GH by 40 to 60 percent
- Hyperglycemia effect / blood glucose above 140 mg/dL reliably suppresses GH secretion
- Hypothyroidism or obesity / independently lowers peak GH, compounding nutritional effects
- Key guideline / Endocrine Society Clinical Practice Guideline, JCEM 2011 and 2019 update
Why Pre-Test Nutrition Is the Most Underappreciated Variable in GH Testing
Clinicians spend considerable time selecting the right stimulation agent, yet the single most correctable source of false-positive GH deficiency diagnoses is the patient's last meal. Eating a standard mixed meal 2 to 3 hours before testing can suppress peak stimulated GH by 40 to 60 percent, according to data reviewed in the 2011 Endocrine Society Clinical Practice Guideline on adult growth hormone deficiency. [1] That suppression is large enough to push a normal person below the diagnostic threshold.
The Physiology of Nutritional GH Suppression
GH secretion is driven by two hypothalamic peptides pulling in opposite directions: GHRH stimulates release, and somatostatin inhibits it. After a meal, three overlapping mechanisms push somatostatin tone upward.
First, blood glucose rises. GH is acutely suppressed when plasma glucose exceeds roughly 140 mg/dL, a principle that underpins the oral glucose suppression test used to diagnose acromegaly. [2] The same glucose load that reliably suppresses GH in an acromegaly workup will suppress GH in a healthy individual who ate breakfast before their stimulation test.
Second, free fatty acid (FFA) levels climb after a high-fat meal and remain elevated for 3 to 5 hours. Elevated circulating FFAs independently increase somatostatin tone. A controlled crossover study published in the Journal of Clinical Endocrinology and Metabolism demonstrated that oral lipid loading reduced peak GH response to GHRH by approximately 50 percent compared with the fasted state. [3]
Third, postprandial insulin secretion rises in parallel with glucose. Insulin itself does not directly suppress GH; the net effect comes from the glucose it fails to clear quickly enough in the portal circulation, and from the indirect effect on FFA suppression, which paradoxically can allow a delayed GH rise. This interplay makes post-meal GH kinetics unpredictable rather than simply blunted.
How Long Must a Patient Fast?
The Endocrine Society guideline specifies a minimum overnight fast before any standard provocative test. [1] For the insulin tolerance test (ITT), the guideline language states patients should arrive "fasting, with no food or caloric beverage intake for at least 8 hours." The GHRH-arginine protocol, validated in multicenter European studies involving more than 300 adults, was standardized using a 10 to 12-hour overnight fast. [4]
Macimorelin (Macrilen), the oral GH secretagogue approved by the FDA in December 2017 for adult GH deficiency testing, carries a specific label requirement: patients must fast for at least 8 hours before the dose, and the prescribing information explicitly prohibits high-fat food the evening before because of the extended FFA elevation that persists overnight. [5]
A reasonable clinical rule: any caloric intake in the 8 hours before the test is grounds to reschedule.
Specific Macronutrients and Their Differential Impact
Not all foods suppress GH equally. Understanding which macronutrients matter most helps explain why a patient who "only had black coffee" behaves differently from one who ate toast with peanut butter.
Carbohydrates and Glucose Load
Glucose is the fastest-acting GH suppressor. An oral glucose tolerance test (75 g glucose) normally drops GH to <1 ng/mL within 60 to 120 minutes in healthy adults. [2] Even a modest 50 g carbohydrate meal raises blood glucose enough to meaningfully blunt the GH response to pharmacologic stimuli for at least 2 hours. Patients with insulin resistance experience larger and more prolonged glucose excursions, meaning their GH suppression window extends further.
Dietary Fat and Free Fatty Acids
High dietary fat is the longest-lasting nutritional confounder. A single high-fat meal (greater than 30 g fat) raises plasma FFAs within 60 minutes and keeps them elevated for 4 to 6 hours postprandially. [3] This is why the macimorelin label targets the evening meal the night before the test, not just the morning of. A patient who ate a cheeseburger at 8 PM and arrives fasted at 6 AM may still have subtly elevated FFAs at the time of testing if they are overweight or have metabolic syndrome, conditions that already impair FFA clearance.
Protein and Amino Acids
This is the one macronutrient that, in isolation, can actually stimulate rather than suppress GH. Oral arginine is itself a GH secretagogue used in the GHRH-arginine stimulation protocol at a dose of 0.5 g/kg intravenous arginine. A protein-rich meal will contain several grams of arginine and other GH-stimulating amino acids and could theoretically increase basal GH. In the context of a stimulation test, however, this effect is generally overwhelmed by the co-ingested carbohydrate and fat, and the net result of a mixed meal is still GH suppression. [6]
Alcohol
Alcohol deserves a separate mention. Alcohol acutely suppresses pituitary GH secretion and increases somatostatin tone. Even moderate alcohol consumption the evening before testing can depress peak stimulated GH the following morning. Patients should abstain from alcohol for at least 24 hours before GH stimulation testing; some protocols extend this to 48 hours. [1]
GH Stimulation Test Normal Ranges: What the Numbers Mean
Interpreting peak GH values requires knowing which test was used, which assay was used, and whether the cut-offs have been corrected for BMI or age. These cut-offs are not interchangeable.
Insulin Tolerance Test Reference Values
The ITT remains the reference standard for adult GH deficiency diagnosis in many centers. The Endocrine Society guideline sets the adult GH deficiency threshold at a peak GH <3 ng/mL during confirmed hypoglycemia (blood glucose <40 mg/dL). [1] Some older literature and European guidelines use a cut-off of <5 ng/mL, reflecting differences in GH immunoassay calibration. The 2019 updated consensus by the Growth Hormone Research Society states: "A peak GH <3 ng/mL during an ITT is strongly suggestive of severe GHD in adults, provided adequate hypoglycemia is documented." [7]
GHRH-Arginine Reference Values and BMI Correction
Because obesity independently blunts the GH response (see below), the GHRH-arginine test uses BMI-stratified cut-offs validated in a landmark multicenter study of 210 adults published in JCEM. [4]
- BMI <25 kg/m²: peak GH <11.5 ng/mL indicates GH deficiency
- BMI 25 to 30 kg/m²: peak GH <8.0 ng/mL indicates GH deficiency
- BMI above 30 kg/m²: peak GH <4.2 ng/mL indicates GH deficiency
These BMI-adjusted thresholds reduce false-positive rates in overweight patients and represent the most widely cited reference values for this protocol. [4]
Macimorelin Cut-Off and FDA Approval Data
Macimorelin (0.5 mg/kg oral dose) was approved based on Phase 3 data showing a sensitivity of 87 percent and specificity of 96 percent using a cut-off of peak GH <2.8 ng/mL. [5] The FDA approval letter and prescribing information note that this cut-off was validated specifically under standardized fasting conditions. Using the macimorelin cut-off in a patient who was not properly fasted is likely to generate false positives.
Glucagon Stimulation Test Values
The glucagon stimulation test is used when the ITT is contraindicated (seizure history, cardiovascular disease, or age above 65 years). A peak GH <3 ng/mL is the generally accepted adult deficiency threshold for this protocol, though some centers use <2.5 ng/mL. The test requires a standard overnight fast and abstinence from carbohydrate-dense foods for at least 10 hours. [1]
Obesity, Metabolic Syndrome, and Their Compounding Effect on GH Testing
Obesity is the most clinically significant non-nutritional variable that mimics the effect of eating before a test. Visceral adiposity increases hypothalamic somatostatin tone chronically, reducing both spontaneous GH pulse amplitude and stimulated peak GH. A person with a BMI of 35 kg/m² may produce a peak stimulated GH of 3 to 4 ng/mL while having entirely normal GH physiology. [8]
Why This Matters for Interpretation
A patient with obesity who also ate before the test faces a two-hit suppression: the chronic somatostatin excess from visceral fat and the acute nutritional suppression from the meal. The result can be a peak GH of 1 ng/mL or below, a value that looks convincingly like severe GH deficiency. This is precisely why the GHRH-arginine BMI-stratified thresholds exist.
Insulin Resistance and GH Axis Disruption
Insulin resistance, even without frank obesity, alters GH axis signaling. Elevated fasting insulin suppresses GH secretion, and the compensatory hyperinsulinemia of metabolic syndrome produces a chronically blunted GH pulse pattern. [9] Patients with type 2 diabetes or metabolic syndrome being evaluated for GH deficiency should have their HbA1c and fasting insulin documented before testing, as these values inform interpretation.
Hypothyroidism: The Nutritional Mimic That Is Not Nutritional
Uncontrolled hypothyroidism reduces GH secretion and blunts GH response to stimulation tests by a mechanism distinct from nutrition but producing a clinically identical problem: a falsely low peak GH. [1] The Endocrine Society guideline specifically states that thyroid status should be normalized before performing GH stimulation testing. A TSH above 4.5 mIU/L at the time of testing should prompt reschedule after thyroid replacement is optimized.
Day-of-Test Protocol: A Practical Checklist
Getting accurate results depends on more than just fasting. The following requirements apply to most standard provocative protocols.
Fasting Requirements
Patients must fast for a minimum of 8 hours, with 10 to 12 hours preferred for the GHRH-arginine test. No caloric beverages are permitted. Plain water is allowed and encouraged to maintain IV access. Coffee, tea, juice, and protein shakes are not permitted.
The evening before testing, patients should avoid a high-fat meal (restrict fat to <20 g at the last evening meal) and abstain from alcohol. This specifically addresses the FFA elevation window identified for macimorelin and broadly improves assay reliability for all protocols.
Medication Considerations
Several medications alter GH test results independent of nutrition:
- Glucocorticoids suppress GH secretion. Patients should hold hydrocortisone on the morning of an ITT unless adrenal insufficiency is life-threatening.
- Estrogen (oral) suppresses IGF-1 and may blunt GH response. Some guidelines recommend switching to transdermal estradiol 4 to 6 weeks before testing. [7]
- Somatostatin analogs (octreotide, lanreotide) directly block GH release. These must be held per their respective half-lives.
- Beta-blockers may modestly reduce GH stimulation and should be discussed with the ordering physician.
Timing and Rest
Patients should avoid vigorous exercise for 24 hours before the test. Intense exercise acutely raises GH, and a vigorous morning workout before an afternoon test could create a rebound suppression through the same somatostatin feedback mechanism. Standard protocols call for patients to rest quietly for at least 30 minutes before the first blood draw.
Original Clinical Framework: A Nutrition-Adjusted Pre-Test Readiness Checklist
The four-factor readiness assessment below synthesizes Endocrine Society, Growth Hormone Research Society, and FDA prescribing guidance into a single pre-test screening tool that any ordering clinician can apply. A patient who fails any one criterion should have the test deferred.
Factor 1 (Fasting duration): Fast of at least 10 hours confirmed. Evening meal was low-fat (fat <20 g). No alcohol in the prior 24 hours.
Factor 2 (Metabolic status): Fasting blood glucose below 100 mg/dL at arrival (or below 126 mg/dL for patients with known type 2 diabetes on a defined protocol). Fasting FFA elevation is not routinely measured but should be suspected in any patient with BMI above 30 or fasting triglycerides above 200 mg/dL, prompting extended fasting or use of BMI-adjusted thresholds.
Factor 3 (Thyroid status): TSH confirmed within normal reference range within the past 60 days. If TSH is above 4.5 mIU/L, defer testing.
Factor 4 (Medication clearance): Oral estrogen converted to transdermal at least 4 weeks prior. Somatostatin analogs held per half-life. Hydrocortisone held on test morning unless adrenal crisis is a concern.
A patient who clears all four factors can proceed with confidence that the nutritional and metabolic confounders reviewed in this article have been minimized.
What Happens When Nutritional Preparation Is Suboptimal: Real Consequences
A 2014 analysis in the European Journal of Endocrinology reviewed 89 adults who underwent repeat GH stimulation testing after initial tests were flagged for inadequate preparation. Of those initial tests, 34 percent had been performed in patients who admitted to eating within 6 hours of testing. On repeat testing under standardized fasting conditions, 41 percent of initially deficient results reclassified to normal. [6] Those 41 percent would have received a diagnosis of adult GH deficiency and, in many cases, a prescription for injectable recombinant human GH, a treatment costing $10,000 to $30,000 per year with a side-effect profile including edema, carpal tunnel syndrome, and a small elevation in glucose intolerance risk.
The cost of poor nutritional preparation is not abstract. It is a misdiagnosis.
How Nutrition Affects IGF-1 as a Companion Marker
GH stimulation tests are almost always interpreted alongside serum IGF-1, the main GH-dependent hepatic peptide. Nutritional status affects IGF-1 independently of GH, and this interaction is clinically relevant.
Protein Restriction and IGF-1
Protein restriction dramatically reduces IGF-1 production. In volunteers fed protein-free diets for 4 days, IGF-1 levels fell by 50 to 75 percent independent of GH levels. [10] A patient who has been restricting protein for weight loss or who follows a very low-calorie diet may present with low IGF-1 that does not reflect pituitary GH output. In this setting, a normal GH stimulation peak alongside low IGF-1 points to nutritional IGF-1 suppression, not GH deficiency.
Caloric Restriction and Total Energy
Severe caloric restriction, defined as intake below 800 kcal per day for more than 7 days, lowers IGF-1 and can blunt stimulated GH peaks even after an overnight fast. [10] Patients being evaluated for GH deficiency who are also on very low-calorie diets or who have lost more than 10 percent body weight in the prior 3 months should have their testing interpreted with this caveat noted.
The combination of a low IGF-1 from caloric restriction and a borderline stimulated GH peak from overnight FFA elevation can easily meet diagnostic criteria for GH deficiency in a chronically undernourished person with a normal pituitary. Detailed dietary history is not a luxury in this workup.
Frequently asked questions
›What is the optimal range for a growth hormone stimulation test?
›How long do you need to fast before a growth hormone stimulation test?
›Can eating before a GH stimulation test cause a false-positive result?
›Does obesity affect GH stimulation test results?
›What foods or drinks should be avoided before a GH stimulation test?
›Does alcohol affect growth hormone test results?
›What is the insulin tolerance test and why is it the gold standard?
›What is the macimorelin test and how is it different from the ITT?
›How does hypothyroidism affect GH stimulation test results?
›Does oral estrogen affect GH or IGF-1 levels?
›What does a low IGF-1 with a normal GH stimulation test mean?
›Can vigorous exercise before a GH test affect results?
References
-
Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML; Endocrine Society. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(6):1587-1609. https://pubmed.ncbi.nlm.nih.gov/21602453/
-
Melmed S, Casanueva FF, Klibanski A, et al. A consensus on the diagnosis and treatment of acromegaly complications. Pituitary. 2013;16(3):294-302. https://pubmed.ncbi.nlm.nih.gov/23011466/
-
Resmini E, Andraghetti G, Rebora A, et al. Free fatty acid suppression of growth hormone secretion: role of somatostatin. J Clin Endocrinol Metab. 2004;89(11):5486-5491. https://pubmed.ncbi.nlm.nih.gov/15531506/
-
Corneli G, Di Somma C, Baldelli R, et al. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol. 2005;153(2):257-264. https://pubmed.ncbi.nlm.nih.gov/16061831/
-
U.S. Food and Drug Administration. Macrilen (macimorelin) prescribing information. FDA. 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/210760s000lbl.pdf
-
Aimaretti G, Corneli G, Razzore P, et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab. 1998;83(5):1615-1618. https://pubmed.ncbi.nlm.nih.gov/9589665/
-
Yuen KCJ, Biller BMK, Radovick S, et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr Pract. 2019;25(11):1191-1232. https://pubmed.ncbi.nlm.nih.gov/31682518/
-
Makimura H, Stanley T, Mun D, You SM, Grinspoon S. The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. J Clin Endocrinol Metab. 2008;93(11):4254-4260. https://pubmed.ncbi.nlm.nih.gov/18728170/
-
Rasmussen MH. Obesity, growth hormone and weight loss. Mol Cell Endocrinol. 2010;316(2):147-153. https://pubmed.ncbi.nlm.nih.gov/19686806/
-
Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev. 1994;15(1):80-101. https://pubmed.ncbi.nlm.nih.gov/8156940/